Citadel Advisors LLC 13D/13G Filings for Ikena Oncology, Inc. (IKNA)

Citadel Advisors LLC 13D and 13G filings for Ikena Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-02-14
4:57 pm
Sale		2023-12-3113GIkena Oncology, Inc.
IKNA		Citadel Advisors LLC14,848
0.400%		-164,746decrease
(-91.73%)		Filing
2023-02-14
08:02 am
Purchase		2022-12-3113GIkena Oncology, Inc.
IKNA		Citadel Advisors LLC179,595
5.900%		2,244increase
(+1.27%)		Filing
2022-02-14
06:12 am
Purchase		2021-12-3113GIkena Oncology, Inc.
IKNA		Citadel Advisors LLC177,351
5.900%		6,105increase
(+3.56%)		Filing
2021-04-09
4:57 pm
Purchase		2021-03-3013GIkena Oncology, Inc.
IKNA		Citadel Advisors LLC171,246
6.600%		171,246increase
(New Position)		Filing